We are live on ! Find out more
CLRB icon

Cellectar Biosciences
CLRB

41 hedge funds and large institutions have $4.38M invested in Cellectar Biosciences in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

8% more funds holding

Funds holding: 38 → 41 (+3)

0% less ownership

Funds ownership: 0.04% → 0.04% (-0%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

35% less capital invested

Capital invested by funds: $6.77M → $4.38M (-$2.4M)

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$720K
2
WVP
Worth Venture Partners
New Jersey
+$165K
3
Citadel Advisors
Citadel Advisors
Florida
+$132K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$46.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$40.4K

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$851K
2
MS
Maven Securities
Jersey
-$491K
3
Renaissance Technologies
Renaissance Technologies
New York
-$262K
4
Morgan Stanley
Morgan Stanley
New York
-$242K
5
QP
Quilter Plc
United Kingdom
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northwestern Mutual Wealth Management
26
Northwestern Mutual Wealth Management
Wisconsin
$13K +$16.1K +67 New
TSS
27
Two Sigma Securities
New York
$9K -$8.91K -37 -44%
PFS
28
Prospera Financial Services
Texas
$9K -$722 -3 -6%
CB
29
Commerce Bank
Missouri
$9K – – –
Jane Street
30
Jane Street
New York
$9K +$11.3K +47 New
SC
31
Scotia Capital
Ontario, Canada
$8K +$241 +1 +3%
DCM
32
Difesa Capital Management
New York
$7K +$7.94K +33 New
JFGIW
33
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$4K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$3K – – –
US Bancorp
35
US Bancorp
Minnesota
$2K – – –
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
$1K – – –
BC
37
Boxer Capital
California
– -$851K -3,067 Closed
HI
38
Harbour Investments
Wisconsin
– -$14.2K -59 -98%
QP
39
Quilter Plc
United Kingdom
– -$16K -57 Closed
LPL Financial
40
LPL Financial
California
– -$13K -47 Closed
ASN
41
Advisory Services Network
Georgia
– -$9K -33 Closed
PNC Financial Services Group
42
PNC Financial Services Group
Pennsylvania
– -$9K -33 Closed
TCM
43
Tradewinds Capital Management
Washington
– -$9K -33 Closed
Wells Fargo
44
Wells Fargo
California
– -$2.41K -10 -91%
TRCT
45
Tower Research Capital (TRC)
New York
– +$722 +3 New
1
2

CLRB Hedge Fund Activity: Q4 2021 in Review

41 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q4 2021, worth a combined $4.38M — down 35% from $6.77M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CLRB positions and 6 closed out — a net gain of 3 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $720K. The largest seller was Boxer Capital, exiting entirely with an estimated $851K sold.

  • 41 institutional investors held Cellectar Biosciences (CLRB) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $4.38M of Cellectar Biosciences stock for Q4 2021, down 35% quarter-over-quarter.
  • 9 funds opened new Cellectar Biosciences positions in Q4 2021 and 6 closed out, a net change of +3 holders.
  • The largest Cellectar Biosciences buyer in Q4 2021 was AIGH Capital Management, an estimated $720K added.
  • The largest Cellectar Biosciences seller in Q4 2021 was Boxer Capital, an estimated $851K sold.

Based on aggregated 13F filings for Q4 2021.